Global equitable access to COVID-19 vaccines estimated to generate economic benefits of at least $153 billion in 2020–21, and $466 billion by 2025, in 10 major economies, according to new report by the Eurasia Group.

Global equitable access to COVID-19 vaccines estimated to generate economic benefits of at least $153 billion in 2020–21, and $466 billion by 2025, in 10 major economies, according to new report by the Eurasia Group.

Aralık 03, 2020

via News (English) - World Health Organization https://ift.tt/37AShBw

Yorumlar